KR
About
Kate brings 27 years of experience in the Medical Device and Pharmaceutical Industry. Previously she held the position of Vice President, Global Clinical and Medical Affairs at Covidien. She has extensive experience in product development in the CNS space through her time at Aspect Medical Systems and Eli Lilly & Company. Kate first joined NeoSync in 2010, leading the company’s clinical and regulatory activities, and later rejoined as President and CEO in April 2015. She holds a BS degree in both Biology and Psychology from the State University of New York.
Position in the VCSift Database
- • 2 investors at Ablative Solutions are tracked.
- • 266 investors hold the President and CEO role in VCSift. Kate Rumrill is one of them.
- • 2,293 investors are based in Boston, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Boston, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Kate
Search Investors